CTAD | Posters & Presentations

This year’s Clinical Trials on Alzheimer’s Disease (CTAD) conference brings together global leaders advancing research and innovation in Alzheimer’s and dementia treatment. We’re proud to be part of this important event connecting academia, industry, and regulatory experts to drive meaningful progress in clinical development.

As pioneers in digital health and cognitive assessment technologies, Cambridge Cognition is committed to supporting advancements in the measurement of cognitive function, improving trial efficiency, and enhancing the understanding of brain health in neurodegenerative diseases.

CTAD offers an exciting opportunity to share perspectives, explore emerging research, and engage with the international Alzheimer’s community. We look forward to connecting with researchers, clinicians, and partners who share our mission to accelerate innovation in neuroscience.

Join us as we celebrate progress, collaboration, and the pursuit of better outcomes for patients worldwide. See you at CTAD 2025!